- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Glenmark secures USFDA nod for OTC Nasal Spray; launches Generic Milnacipran tablets in US | 3 | capitalmarket.com | ||
| Mo | Glenmark Pharma gains as US arm to launch Potassium Phosphates Injection | 2 | capitalmarket.com | ||
| 05.03. | FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent | 4 | FiercePharma | ||
| 04.03. | Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic | 2 | Contract Pharma | ||
| 04.03. | Glenmark Pharmaceuticals: Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity | 193 | PR Newswire | ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S.... ► Artikel lesen | |
| 04.03. | Glenmark Pharma secures USFDA nod for Fluticasone Propionate Inhalation Aerosol | 7 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 04.03. | Glenmark Wins US FDA Approval For Inhalation Therapy Medicine With 180 Day Generic Exclusivity | 4 | The Free Press Journal | ||
| 27.02. | Glenmark Pharma's USA arm to market Sodium Phosphate injection in April 2026 | 3 | capitalmarket.com | ||
| 26.02. | Glenmark Pharmaceuticals Ltd gains for third straight session | 2 | capitalmarket.com | ||
| 22.01. | EQS-News: AcuCort AB: AcuCort schließt kommerzielle Vereinbarung mit Glenmark Pharmaceuticals für Deutschland und fünf weitere europäische Länder | 457 | EQS Group (DE) | EQS-News: AcuCort AB
/ Schlagwort(e): Joint Venture/Produkteinführung
AcuCort schließt kommerzielle Vereinbarung mit Glenmark Pharmaceuticals für Deutschland und fünf weitere... ► Artikel lesen | |
| 22.01. | AcuCort Signs Glenmark Deal To Market Zeqmelit In Six European Countries | 6 | RTTNews | ||
| 22.01. | ACUCORT AB: AcuCort signs commercial agreement with Glenmark Pharmaceuticals for Germany and five additional European countries | 4 | Cision News | ||
| 23.12.25 | Glenmark Pharma's US arm launches Epinephrine Injection in American market | 6 | capitalmarket.com | ||
| 22.12.25 | Glenmark Pharmaceuticals Ltd up for third consecutive session | 8 | capitalmarket.com | ||
| 11.12.25 | Glenmark Pharma's U.S. arm to launch Leucovorin Calcium Injection in the U.S. Market | 5 | capitalmarket.com | ||
| 01.12.25 | Glenmark Pharmaceuticals: Cosmo and Glenmark Announce Market Authorisation of Winlevi (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe | 1.108 | PR Newswire | DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission... ► Artikel lesen | |
| 01.12.25 | Glenmark Pharma's Chhatrapati Sambhajinagar facility clears USFDA inspection with zero observations | 4 | capitalmarket.com | ||
| 27.11.25 | Drugmaker Glenmark Pharma Receives Establishment Inspection Report From US Health Regulator For Formulations Manufacturing Facility In North Carolina | 3 | The Free Press Journal | ||
| 27.11.25 | Glenmark Pharmaceuticals Ltd up for third straight session | 2 | capitalmarket.com | ||
| 27.11.25 | Glenmark Pharma gains after receiving positive USFDA EIR for Monroe Facility | 6 | capitalmarket.com |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,267 | -2,66 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| CSPC PHARMA | 0,980 | -1,25 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - GLP-1/GIP RECEPTOR DUAL-BIASED AGONIST POLYPEPTIDE LONG-ACTING INJECTION (SYH2082 INJECTION) OBTAINS CLINICAL ... | ||
| WUXI BIOLOGICS | 3,674 | -1,37 % | WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - WuXi Biologics (2269. HK,WXIBF), a Contract Research, Development, and Manufacturing Organisation, announced on Tuesday that it has signed a license and... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,098 | +1,65 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| GEDEON RICHTER | 29,540 | -1,66 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 12,000 | +0,84 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 6,700 | +1,52 % | ASPEN PHARMACARE HOLDINGS LIMITED - Distribution of circular to shareholders and notice of general meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,270 | +4,10 % | SH PHARMA (02607): NOTICE OF BOARD MEETING | ||
| LUYE PHARMA | 0,256 | -3,76 % | LUYE PHARMA (02186): NOTICE OF BOARD MEETING | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,148 | -1,99 % | SIHUAN PHARM (00460): NOTICE OF BOARD MEETING | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,494 | -0,40 % | CHINARES PHARMA (03320): ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2025 | ||
| HANSOH PHARMACEUTICAL | 3,580 | -0,56 % | HANSOH PHARMA (03692): DATE OF BOARD MEETING | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,950 | -1,55 % | SHINEWAY PHARM (02877): NOTICE OF BOARD MEETING | ||
| KALBE FARMA | 0,042 | -9,78 % | KLBF to buyback shares, allocating IDR 250 billion: KLBF plans to repurchase shares worth IDR 250 billion over ... | ||
| BAYER | 39,030 | +1,47 % | Aktien Frankfurt Ausblick: Stabilisierung - Unicredit bietet für Commerzbank | FRANKFURT (dpa-AFX) - Der Dax dürfte recht stabil in den elften Handelstag seit Kriegsausbruch im Iran starten. Der X-Dax signalisierte für den deutschen Leitindex rund eine Stunde vor Handelsbeginn... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.